Next Article in Journal
Determination of Fosetyl-Aluminum in Wheat Flour with Extract-Dilute-Shoot Procedure and Hydrophilic Interaction Liquid Chromatography Tandem Mass Spectrometry
Previous Article in Journal
On Process Intensification through Membrane Storage Reactors
Previous Article in Special Issue
Influence of Harvest Time, Method of Preparation and Method of Distillation on the Qualitative Properties of Organically Grown and Wild Helichrysum italicum Immortelle Essential Oil
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Separations
Volume 8
Issue 11
10.3390/separations8110196
separations-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Selective Separation and Analysis of Catecholamines in Urine Based on Magnetic Solid Phase Extraction by Mercaptophenylboronic Acid Functionalized Fe3O4-NH2@Au Magnetic Nanoparticles Coupled with HPLC

by
Qing Han
1,
Xiaoxiao Wu
1,
Yi Cao
2,
Hua Zhang
2,
Yuqin Zhao
3,
Xuejun Kang
1,* and
Huaiyuan Zhu
2,*
1
Key Laboratory of Child Development and Learning Science, Ministry of Education, Research Center for Learning Science, School of Biological Sciences & Medical Engineering, Southeast University, Nanjing 210096, China
2
China Tobacco Jiangsu Industrial Co., Ltd., Nanjing 210019, China
3
Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing 210001, China
*
Authors to whom correspondence should be addressed.
Separations 2021, 8(11), 196; https://doi.org/10.3390/separations8110196
Submission received: 13 September 2021 / Revised: 7 October 2021 / Accepted: 12 October 2021 / Published: 20 October 2021
(This article belongs to the Special Issue Advance of Separation and Purification Technology in Biotechnology and Biochemistry Macromolecule)
Browse Figures
Versions Notes

Abstract

:
A novel magnetic solid phase extraction based on mercaptophenylboronic acid (MPBA)-functionalized Fe3O4-NH2@Au nanomaterial (Fe3O4-NH2@Au-MPBA) was developed for selective separation and enrichment of catecholamines (including dopamine, norepinephrine and adrenaline). Fe3O4-NH2@Au-MPBA nanoparticles were achieved by self-assembly-anchoring MPBA molecules on the surface of Fe3O4-NH2@Au nanocomposites, which were synthesized via a facial ultrasonic auxiliary in situ reduction process. The interaction between cis-diol from catecholamines and boronic acid was reversible and could be flexibly controlled by adjusting pH value. The catecholamines could be quickly adsorbed by Fe3O4-NH2@Au-MPBA in weak alkaline solution (pH 8.0–9.0) and subsequently released in acid solution (pH 1.0–2.0). The process of adsorption and dissociation was very fast. Furthermore, the three catecholamines could be detected in urine from children by high performance liquid chromatography (HPLC) with electrochemical detector. Under optimal conditions, norepinephrine (NE), epinephrine (EP) and dopamine (DA) were separated very well from internal standard and exhibited a good linearity in the range of 2.5–500.0 ng mL−1, with correlation coefficients of r2 > 0.9907. Limits of detection (LOD) (signal to noise = 3) were 0.39, 0.27 and 0.60 ng mL−1 for NE, EP and DA, respectively. Recoveries for the spiked catecholamines were in the range of 85.4–105.2% with the relative standard deviation (RSD) < 11.5%.

1. Introduction

Catecholamines (CAs), which include norepinephrine (NE), epinephrine (EP) and dopamine (DA), are important neurotransmitters and hormones released by the adrenal glands and sympathetic nervous system [1]. Currently, it is known that catecholamines are involved in some of the most prevalent human pathologies, such as neurological disorders such as Parkinson’s [2], pheochromocytoma [3] and schizophrenia [4]. Hence, monitoring the concentration of catecholamines in biological fluids including blood, urine and specific tissue has attracted considerable interest in diagnostic analysis and biological systems [5,6].
In spite of the great diversity of analytical approaches that have been developed in recent years, the detection of catecholamines in biological samples remains a hot spot in analytical fields [7,8]. High-performance liquid chromatography (HPLC) is an analytical method routinely used for the separation and quantification of catecholamines in clinical laboratories [9,10], usually coupled with electrochemical [11], fluorescence [12] or mass spectrometry detection [13]. Among the detectors, electrochemical detectors [14,15] attract more preference due to good selectivity, highly sensitive characteristics, a lack of need for derivatization and low detection cost. However, matrix effects, extremely low concentrations and chemical instability of catecholamines in biological samples are major difficulties encountered in their analysis.
To solve these problems, optimization of the sample pretreatment process plays an important role in the enrichment and separation of targets. The common sample preparation methods for extracting catecholamines in chromatographic analysis involves liquid–liquid extraction (LLE) [16] and solid phase extraction (SPE) [17,18]. Nevertheless, LLE is labor-intensive and time-consuming [19] and encounters low selectivity and extraction yields. SPE is widely adopted for the extraction and concentration of catecholamines, possibly due to the high extraction recoveries and selectivity [20].
Magnetic solid phase extraction (MSPE) is a flexible solid phase extraction technology. The magnetic adsorbents can be recycled and reused easily, which is cost-effective and environmentally friendly. Fe3O4 magnetic nanoparticles (NPs), commonly used magnetic cores, are easily oxidized in air and have a tendency to aggregate [21,22]. To overcome these problems, different materials such as metals [23], metal oxides [24], mesoporous [25], polymers [26], graphene [27] and dendrimers [28] have been developed to hybridize with Fe3O4 NPs. In recent years, gold-coated Fe3O4 (Fe3O4@Au) magnetic NPs have drawn intense scientific and technological interest for potential applications in disease diagnosis and therapy [29], biological detection [30], catalytic application and separation science [31].
In recent years, phenylboronic acid (PBA) and its derivatives containing boronic acid functional groups have been employed for selective capture and enrichment of cis-diol molecules (carbohydrates [32], mucin [33], nucleosides and glycoconjugates) from biological samples. Owing to the ability to form a five- or six-membered boronate ester [34] via reversible covalent interactions with the position at cis-1, 2- or 1, 3-diol, they exhibit a high selectivity for targets. The formation and dissociation of boronic esters are controlled by appropriately adjusting the pH value. 4-mercaptophenylboronic acid (4-MPBA) is a thiol-containing boronic acid compound which has been used to modify gold NPs for the selective interactions with cis-diol structure on sugars [35], sialic acid, protein kinase and alpha-fetoprotein [36,37,38,39]. However, to the best of our knowledge, we have not seen this idea used for the selective separation of catecholamines.
In this report, a novel magnetic nanocomposite, 4-MPBA-functionalized Fe3O4-NH2@Au (Fe3O4-NH2@Au-MPBA), was prepared and used for the pretreatment of catecholamines in urine and followed by HPLC-electrochemical detection. The cis-diol structures of catecholamines were able to form ring boronate ester structures with boronic acid groups of Fe3O4-NH2@Au-MPBA nanocomposite by covalent bond interaction. The morphologies and magnetization saturation values of the prepared magnetic material were explored by scanning electron microscope (SEM) and vibrating sample magnetometer (VSM). The analytical performances of the method were evaluated before determining catecholamines in urine samples.

2. Materials and Methods

2.1. Reagents and Chemicals

Dopamine (DA) and norepinephrine (NE) were purchased from Yuanye biotechnology Co., Ltd. (Shanghai, China). Epinephrine (EP) was bought from Chromadex (Irvine, CA, USA). 3,4-dihydroxybenzylamine hydrobromide (DHBA) acting as internal standard (IS) was purchased from Aladdin Reagent (Shanghai, China). 4-mercaptophenylboronic acid (MPBA) was bought from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). Molecular structures of these compounds are shown in Figure 1.
Stock solutions (1 mg mL−1) of NE, DA and IS were prepared by dissolving 5 mg of standard substance in 5 mL of deionized water. Stock solution (1 mg mL−1) of EP was prepared by dissolving 5 mg of standard substance in 100 μL 0.01 mol L−1 HCl solution before diluting to 5 mL by deionized water. All solutions were stored at −20 °C until use.
The artificial urine reported in the reference [40] was used in recovery tests. The artificial urine consisted of 19.4 mg mL−1 of urea, 8.0 mg mL−1 of NaCl, 1.1 mg mL−1 of magnesium sulfate and 0.6 mg mL−1 of CaCl2, and the solution was adjusted to pH 8.0 with 1 mol L−1 NaOH. Spiked artificial urine solution was prepared containing CAs (NE, EP and DA) in the concentrations of 10, 50 and 200 ng mL−1, and then 2 mL of the spiked solution was mixed with 100 μL of IS (1000 ng mL−1).

2.2. Instruments

A pH meter (Shanghai, China) with a composite electrode was used for the pH values. Special indicator papers indicating pH 6.9–8.4 were bought from SSS Reagent Company (Shanghai, China). An analytical balance (Shanghai, China) was used for weight measurement. A Hitachi S-3400N scanning electron microscope (SEM, Hitachi, Tokyo, Japan) was used at an acceleration voltage of 20.0 kV. Magnetic measurement was carried out using a 7407 vibrating sample magnetometer (Lakeshore, Columbus, OH, USA) at room temperature.

2.3. Chromatography Conditions

A Thermo Scientific UltiMate 3000 ECD UHPLC system based on a glass carbon electrode detector (Thermo Fisher Scientific, Waltham, MA, USA) equipped with a Kromasil C18 column (5 μm, 250 mm × 4.6 mm) was used. The mobile phase was isocratic elution and consisted of acetonitrile and 0.7% NaH2PO4 in water (5.5:94.5, v/v) with addition of citric acid (35 mmol L−1), EDTA (0.25 mmol L−1) and 1-heptane sulfonic acid sodium salt (2 mmol L−1). The pH of the mobile phase was adjusted to pH 4.0 by adding saturated NaOH solution. The run was performed at 1.0 mL min−1 with the column oven temperature at 30 °C. The injection volume was 20 μL and the working potential was 700 mV.

2.4. Preparation of Phenylboronic Acid-Functionalized Fe3O4-NH2@Au (Fe3O4-NH2@Au-MPBA)

The Fe3O4 NPs were prepared through reducing the solution of Fe (II) and Fe (III) chlorides of the molar ratio 1:2 with 30% ammonia solution. Appropriate Fe3O4 NPs were modified by APTES through stirring in 10% (v/v) APTES solution in absolute ethyl alcohol for 12 h. The obtained Fe3O4 NPs modified by -NH2 groups (Fe3O4-NH2) were magnetically separated, washed with ethanol and dispersed in ethanol.
Next, 500 mg Fe3O4-NH2 NPs, 50 mL of 2% HAuCl4 and 300 mL distilled water were mixed for over 10 min by sonication, and then 50 mmol L−1 KBH4 solution was dropped into the above mixture under ultrasound until the color changed to purple. Another 5 min of sonication was performed. The Fe3O4-NH2@Au NPs were obtained by magnetic separation.
An amount of 500 mg Fe3O4-NH2@Au NPs was added to 100 mL 1 mg mL−1 of MPBA solution under stirring to complete the covalent binding between the Au shell and sulfydryl (-SH). Fe3O4-NH2@Au-MPBA composites were obtained, then separated and washed with distilled water based on external magnetic field. After that, the magnetic nanocomposites were dried in a vacuum oven at 40 °C for 24 h.

2.5. Sample Collection

To investigate the suitability of the proposed method, a pilot study was conducted by analyzing urinary samples from healthy volunteers. The urine samples from 6 healthy children aged 4–6 years (3 boys and 3 girls). Their morning urine samples were collected into sterile urine cups. They were then immediately transferred to polypropylene tubes and stored in a –20 °C refrigerator.
The study was carried out according to the principles of the Declaration of Helsinki (World Medical Association 2008). Written informed consent was obtained from the legal guardians of the volunteers. This study was approved by the Ethics Committee of Zhongda Hospital Affiliated to Southeast University.

2.6. Sample Pretreatment

When analyzing samples, the stored 2.5 mL urine samples were thawed by incubation at 37 °C for 5 min and centrifuged for 5 min at 10,000 rpm. Then, 2 mL of supernatant, 100 μL of 1 μg mL−1 DHBA and 5 mg Fe3O4-NH2@Au-MPBA NPs were added into a glass spawn bottle, and the pH was adjusted to 8.0 by adding moderate amounts of 0.01 mol L−1 NaOH. After that, the mixture was stirred for about 10 min at room temperature, and the supernatant was removed by external magnetic field. An amount of 200 μL of 0.5% H3PO4 solution (pH = 2.0) was added for desorbing the analytes. 20 μL of eluent was injected into HPLC for analysis. The process schematic for the preparation of the magnetic Fe3O4-NH2@Au-MPBA NPs and the pretreatment of samples are shown in Figure 2.

3. Results and Discussion

3.1. Characterization

The morphologies of Fe3O4-NH2@Au NPs were examined by SEM at 20.0 kV (8.2 mm, 40.0k SE) (Figure 3A). The size distribution of Fe3O4-NH2@Au NPs is shown in Figure 3B, where we can see that the size of Fe3O4-NH2@Au NPs was uniform, and the average particle size was about 150 nm. The energy-dispersive spectroscopy (EDS) results showed the existence of Fe, C, Si and O elements in Fe3O4-NH2 samples (Figure 3C). Moreover, the Au elements could be found in Fe3O4-NH2@Au material (Figure 3D), which indicated that Fe3O4-NH2@Au NPs were successfully prepared.
The profile of magnetization loops in Figure 4 revealed that the Fe3O4-NH2 and Fe3O4-NH2@Au NPs are superparamagnetic [29]. The magnetization saturation (Ms) values of Fe3O4-NH2 and Fe3O4-NH2@Au NPs were determined as 32.1 and 22.0 emu/g, respectively. The Fe3O4-NH2@Au NPs showed slightly lower Ms values than that of Fe3O4-NH2 due to the surface conjugation of Au NPs on Fe3O4-NH2.
In the inset, the two bottles are both Fe3O4-NH2@Au NPs suspension solution. The composite NPs were able to be magnetically separated by an external magnetic field, which indicated that the enrichment and separation of Fe3O4-NH2@Au NPs during the extraction process can be regulated by an external magnetic field.

3.2. Optimization of the Extraction Condition

3.2.1. Optimizing the Mass Ratio of Au3+ and Fe3O4-NH2

The effect of the mass ratios of Fe3O4-NH2 and Au3+ on magnetic separation time was studied. As shown in Figure 5A, when the mass ratio of Fe3O4-NH2 and Au3+ was 3:1, the magnetic separation time was less than 2 minutes; however, too little Au3+ may reduce the functionalized molecule numbers of MPBA, which would reduce the sites of interaction for targets. With the increase in Au3+, the magnetic separation time was gradually prolonged. However, when the mass ratio was 1:2, the gold nanoparticles were not completely wrapped on the surface of Fe3O4-NH2 NPs, which was very wasteful for Au3+. When the mass ratio was 1:1.5, the magnetic separation time was 15 minutes, which was too long for rapid pretreatment for samples. Therefore, the mass ratio of 1:1 between Fe3O4-NH2 NPs and Au3+ was chosen.

3.2.2. Optimizing the pH Value of the Adsorption Solution

The pH value of adsorption solution was a critical factor for boronate affinity. Most boronic acids are generally weak acids, having a pKa values of 8.0–9.0. With pH less than the pKa value, most of them still exist in trigonal form [-B(OH)2], which cannot react with cis-diol groups [41]. For phenylboronic acids, when the pH is greater than the pKa value of the phenylboronic acid ligand, the phenylboronic acid group is transformed to tetrahedral anionic form [-B(OH)4−] under alkaline conditions [35]. Subsequently, [-B(OH)4−] bonds with cis-1,2-diol units to form a stable 5-membered cyclic ester. This is in good agreement with the results obtained from MPBA functionalized Fe3O4-NH2@Au. In this work, we studied the effect of adsorption pH value (5.0–9.0) on adsorption performance, and the results are shown in Figure 5B. As described above, the phenylboronic acids were the sole functional group on Fe3O4-NH2@Au nanoparticles, and thus the adsorption rates of adsorbents for the three catecholamines were pH-dependent. The adsorption rates improved when the pH value increased from 5.0 to 8.0 and then remained almost unchanged. Thus, pH 8.0 was selected for adsorption.

3.2.3. Optimizing Reaction Time of MPBA and Fe3O4-NH2@Au

The interaction time between MPBA and Fe3O4-NH2@Au NPs is very important, as it could impact the adsorption performance of the magnetic NPs for catecholamines. The relationships between reaction time (2–7 h) and extraction efficiency were explored. As shown in Figure 5C, when reaction time was more than 3h, the extraction efficiency remained nearly unchanged. Thus, 3 h was chosen as the reaction time of MPBA and Fe3O4-NH2@Au NPs.

3.2.4. The pH Value of Desorption Solvent

The pH value of the eluent has an important effect on the formation of boronate ester, because the reversible covalent interactions could be adjusted by pH between the positions of the cis-diol moieties of the targets and the hydroxyl groups of the boronic acid ligand. Acidic environments can break the ester bond and make the target dissociate from Fe3O4-NH2@Au-MPBA NPs. The pH value (1.0–7.0) was investigated for the eluent. With the decrease in pH value of the eluent, the extraction recovery of the targets increased gradually. When the pH value was 2.0, the extraction recovery of the CAs reached the maximum. As the pH value continued to decrease, the recoveries almost remained unchanged. Therefore, pH 2.0 was chosen as the acidity value for the eluent (Figure 5D).

3.2.5. Exploring the Elution Time

In order to obtain the best extraction performance, different elution time from 2 to 30 min was optimized. Figure 5E demonstrated the relationship between the elution time and the recoveries. When elution time was shorter than 10 min, the extraction recovery increased with the extraction time increasing. When elution time was longer than 10 min, the recovery of CAs was almost no longer changed. Therefore, 10 min was chosen as the final elution time.

3.3. Method Evaluation

To test the linearity, we analyzed the mixed solutions of NE, EP and DA at the concentrations of 2.5, 5.0, 10.0, 20.0, 100.0 and 500.0 ng/mL for each target, which were prepared using artificial urine. Quantification was worked out using internal standard (IS) method. The calibration equation was calculated by the HPLC-ECD peak areas ratio and the concentration ratios of analytes and IS. The analysis performances of the established method for the detection of catecholamines are summarized in Table 1.
The intra-day and inter-day precision and accuracy were evaluated for artificial urine samples spiked with catecholamines at the concentrations of 10, 50 and 200 ng mL−1 based on the above pretreatment method. The limits of detection (LOD), defined as the signal-to-noise ratio of 3:1, and limits of quantification (LOQ), defined as a signal-to-noise ratio of 10:1, were calculated; the results are listed in Table 1. Results showed that good linearity of the targets was achieved in the range of 2.5–500.0 ng mL−1 with the correlation coefficients (r2) of 0.9911, 0.9935 and 0.9907 for NE, EP and DA, respectively. The LOQ were 1.3, 0.9 and 2.0 ng mL−1 (S/N = 10), and LOD (S/N = 3) were 0.39, 0.27 and 0.60 ng mL−1 for NE, EP and DA, respectively. The RSDs (relative standard deviations) for the catecholamines were from 6.1% to 10.7% for intra-day determination (n = 5) and from 7.4% to 11.5% for inter-day determination (n = 5).
The comparison of recoveries obtained by the present method and a reference method [42] has been added in Table S1 in the Supplementary. The results showed that the prepared method has good extraction recoveries for catecholamines.

3.4. Reproducibility and Stability

The relative standard deviation (RSD, %) of adsorption quantities was 8.1% for six batches of Fe3O4-NH2@Au-MPBA NPs, and 7.3% for one batch used 10 times. The adsorption capacities of Fe3O4-NH2@Au-MPBA NPs for catecholamines decreased by approximately 7.5% after one month. The data above showed that the prepared magnetic composite nanoparticles were a reliable and stable adsorbent for catecholamines.

3.5. Application of the Method to Real Samples

To evaluate the application of the prepared magnetic Fe3O4-NH2@Au-MPBA NPs, urine samples were analyzed using internal standard method. As shown in Figure 6, A was the liquid chromatogram of CAs at 20 ng mL−1 in artificial urine with the extraction by magnetic NPs. The liquid chromatogram of a real urine sample (Figure 6B) without the pretreatment by Fe3O4-NH2@Au-MPBA NPs exhibited many impurity peaks. Figure 6C was the liquid chromatogram of a real urine sample with the pretreatment by Fe3O4-NH2@Au-MPBA NPs, where we can find fewer impurity peaks compared with Figure 6B. The results showed that Fe3O4-NH2@Au-MPBA NPs have a highly selective adsorption for catecholamines.
First morning urinations, free of interference of medications and foods, were collected. Free catecholamines were measured in the morning urine samples from six healthy children using our developed method. The concentrations of CAs (NE, EP and DA) of the samples detected by the prepared method are shown in Table 2. The results showed that Fe3O4-NH2@Au-MPBA NPs coupled with HPLC-ECD could be successfully used for the detection of CAs.

4. Conclusions

Fe3O4-NH2@Au-MPBA magnetic nanocomposites were synthesized in a simple method first and employed as adsorbents for the selective extraction of NE, EP and DA based on external magnetic field. 4-MPBA was modified on the surface of Fe3O4-NH2@Au NPs through Au–S bond. The interaction between catecholamines and Fe3O4-NH2@Au-MPBA magnetic NPs is based on the covalent bond of borate ester. The adsorption and desorption of catecholamines could be easily achieved through flexibly adjusting the pH value of solution. The SPE based on magnetic nanocomposite coupled with HPLC-electrochemical detection for the separation and analysis of catecholamines in human urine exhibited good sensitivity and selectivity.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/separations8110196/s1, Figure S1: The SEM graph of PS-PCE, Table S1: The comparison of the extraction recoveries for the mixed catecholamines standard in artificial urine at the concentration of 100 ng/mL extracted by the present method and a reference method.

Author Contributions

Methodology, Q.H., Y.C., Y.Z. and H.Z. (Hua Zhang); formal analysis, Q.H.; resources, Y.Z., H.Z. (Huaiyuan Zhu). and X.K.; data curation, Q.H. and X.W.; writing—original draft preparation, Q.H.; writing—review and editing, X.K. funding acquisition, X.K. All authors have read and agreed to the published version of the manuscript.

Funding

We thank the National Key Research and Development Plan of China (No. 2018YFF0215204), the National Science Foundation of China (No. 81673230) and the Social Development Research Program of Jiangsu Province Science and Technology department (Project No. BE2020627) for their financial support.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Ethics Committee of Zhongda Hospital Affiliated to Southeast University (protocol code 2019ZDKYSB083 and 8 February 2019).

Informed Consent Statement

Informed consent was obtained from all subjects and guardians involved in the study. Written informed consent has been obtained from the patient(s) and the guardians to publish this paper.

Data Availability Statement

The data presented in this study is available in supplementary material.

Acknowledgments

The authors are thankful to Juan Chen, a teacher of Tianhui Road Kindergarten, Jiangning District, Nanjing, China for her support.

Conflicts of Interest

All authors have read this paper and approved to submit it to this journal. There are no conflicts of interest for any authors in relation to the submission.

References

  1. Barnes, M.A.; Carson, M.J.; Nair, M.G. Non-traditional cytokines: How catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system. Cytokine 2015, 72, 210–219. [Google Scholar] [CrossRef] [Green Version]
  2. Goldstein, D.S.; Kopin, I.J.; Sharabi, Y. Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders. Pharmacol. Ther. 2014, 144, 268–282. [Google Scholar] [CrossRef] [Green Version]
  3. Eisenhofer, G.; Peitzsch, M. Laboratory Evaluation of Pheochromocytoma and Paraganglioma. Clin. Chem. 2014, 60, 1486–1499. [Google Scholar] [CrossRef] [Green Version]
  4. Schulze, J.; Vogelgesang, A.; Dressel, A. Catecholamines, steroids and immune alterations in ischemic stroke and other acute diseases. Aging Dis. 2014, 5, 327–339. [Google Scholar]
  5. Bergquist, J.; Ściubisz, A.; Kaczor, A.; Silberring, J. Catecholamines and methods for their identification and quantitation in biological tissues and fluids. J. Neurosci. Methods 2002, 113, 1–13. [Google Scholar] [CrossRef]
  6. Sangubotla, R.; Kim, J. Recent trends in analytical approaches for detecting neurotransmitters in Alzheimer’s disease. Trends Anal. Chem. 2018, 105, 240–250. [Google Scholar] [CrossRef]
  7. Chauhan, N.; Soni, S.; Agrawal, P.; Balhara, Y.P.S.; Jain, U. Recent advancement in nanosensors for neurotransmitters detection: Present and future perspective. Process. Biochem. 2020, 91, 241–259. [Google Scholar] [CrossRef]
  8. Baranwal, A.; Chandra, P. Clinical implications and electrochemical biosensing of monoamine neurotransmitters in body fluids, in vitro, in vivo, and ex vivo models. Biosens. Bioelectron. 2018, 121, 137–152. [Google Scholar] [CrossRef] [PubMed]
  9. Tokinoya, K.; Shishikura, Y.; Sekine, N.; Aoyagi, A.; Yoshida, Y.; Aita, Y.; Sugasawa, T.; Nabekura, Y.; Takekoshi, K. Plasma free metanephrine and normethanephrine levels correlated toplasma catecholamine after acute running in amateur runner. J. Exerc. Sci. Fit. 2021, 19, 178–181. [Google Scholar] [CrossRef]
  10. Watson, A.M.D.; Gould, E.A.M.; Penfold, S.A.; Lambert, G.W.; Pratama, P.R.; Dai, A.; Gray, S.P.; Head, G.; Jandeleit-Dahm, K.A. Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen Species. Front. Physiol. 2019, 10, 309. [Google Scholar] [CrossRef]
  11. Lomae, A.; Nantaphol, S.; Kondo, T.; Chailapakul, O.; Siangproh, W.; Panchompoo, J. Simultaneous determination of beta-agonists by UHPLC coupled with electrochemical detectioin based on palladium nanoparticles modified BDD electrode. J. Electroanal. Chem. 2019, 840, 439–448. [Google Scholar] [CrossRef]
  12. Huang, X.; Guo, X.-F.; Wang, H.; Zhang, H.-S. Analysis of catecholamines and related compounds in one whole metabolic pathway with high performance liquid chromatography based on derivatization. Arab. J. Chem. 2019, 12, 1159–1167. [Google Scholar] [CrossRef] [Green Version]
  13. Chen, D.; Zhang, J.-X.; Cui, W.-Q.; Zhang, J.-W.; Wu, D.-Q.; Yu, X.-R.; Luo, Y.-B.; Jiang, X.-Y.; Zhu, F.-P.; Hussain, D.; et al. A simultaneous extraction/derivatization strategy coupled with liquid chromatography–tandem mass spectrometry for the determination of free catecholamines in biological fluids. J. Chromatogr. A 2021, 1654, 462474. [Google Scholar] [CrossRef]
  14. Torul, H.; Gumustas, M.; Urguplu, B.; Uzunoglu, A.; Boyaci, I.H.; Celikkan, H.; Tamer, U. Disposable electrochemical flow cell with paper-based electrode assemble. J. Electroanal. Chem. 2021, 891, 115268. [Google Scholar] [CrossRef]
  15. Zhou, X.; Zhu, A.; Shi, G. Selective extraction and analysis of catecholamines in rat blood microdialysate by polymeric ionic liquid-diphenylboric acid-packed capillary column and fast separation in high-performance liquid chromatography-electrochemical detection. J. Chromatogr. A 2015, 1409, 125–131. [Google Scholar] [CrossRef]
  16. Tsuchiya, H.; Hayashi, T. High-performance liquid chromatographie analysis of catecholamines in biological samples by liquid/liquid extraction prepurification. J. Pharmacol. Methods 1990, 23, 21–30. [Google Scholar] [PubMed]
  17. Betzabeth, E.B.M.; Fabienne, M.; Jérome, R.; Claire, D.; Vincent, D. Evaluation of boronate affinity solid-phase extraction coupled in-line to capillary isoelectric focusing for the analysis of catecholamines in urine. Anal. Chim. Acta 2018, 1034, 195–203. [Google Scholar]
  18. Woo, H.I.; Yang, J.S.; Oh, H.J.; Cho, Y.Y.; Kim, J.H.; Park, H.-D.; Lee, S.-Y. A simple and rapid analytical method based on solid-phase extraction and liquid chromatography–tandem mass spectrometry for the simultaneous determination of free catecholamines and metanephrines in urine and its application to routine clinical analysis. Clin. Biochem. 2016, 49, 573–579. [Google Scholar] [CrossRef]
  19. Bicker, J.; Fortuna, A.; Alves, G.; Falcão, A. Liquid chromatographic methods for the quantification of catecholamines and their metabolites in several biological samples—A review. Anal. Chim. Acta 2013, 768, 12–34. [Google Scholar] [CrossRef] [PubMed]
  20. Chen, L.; Wang, H.; Xu, Z.; Zhang, Q.; Liu, J.; Shen, J.; Zhang, W. High-throughput and selective solid-phase extraction of urinary catecholamines by crown ether-modified resin composite fiber. J. Chromatogr. A 2018, 1561, 48–55. [Google Scholar] [CrossRef]
  21. Pan, S.; Zhang, Y.; Shen, H.; Hu, M. An intensive study on the magnetic effect of mercapto-functionalizednano-magnetic Fe3O4 polymers and their adsorption mechanism for the removal of Hg (II) from aqueous solution. Chem. Eng. J. 2012, 210, 564–574. [Google Scholar] [CrossRef]
  22. Peng, L.; Qin, P.; Lei, M.; Zeng, Q.; Song, H.; Yang, J.; Shao, J.; Liao, B.; Gu, J. Modifying Fe3O4 nanoparticles with humic acid for removal of Rhodamine B in water. J. Hazard. Mater. 2012, 209–210, 193–198. [Google Scholar] [CrossRef] [PubMed]
  23. Cui, W.; Xue, D.; Tan, N.; Zheng, B.; Jia, M.; Zhang, W. Pt supported on octahedral Fe 3 O 4 microcrystals as a catalyst for removal of formaldehyde under ambient conditions. Chin. J. Catal. 2018, 39, 1534–1542. [Google Scholar] [CrossRef]
  24. Guo, H.; Zhao, A.; He, Q.; Chen, P.; Wei, Y.; Chen, X.; Hu, H.; Wang, M.; Huang, H.; Wang, R. Multifunctional Fe3O4@mTiO2@noble metal composite NPs as ultrasensitive SERS substrates for trace detection. Arab. J. Chem. 2019, 12, 2017–2027. [Google Scholar] [CrossRef]
  25. Huang, Y.; Zhang, Y.; Liu, D.; Li, M.; Yu, Y.; Yang, W.; Li, H. Facile synthesis of highly ordered mesoporous Fe3O4 with ultrasensitive detection of dopamine. Talanta 2019, 201, 511–518. [Google Scholar] [CrossRef] [PubMed]
  26. Haddaoui, M.; Sola, C.; Raouafi, N.; Korri-Youssoufi, H. E-DNA detection of rpoB gene resistance in Mycobacterium tuberculosis in real samples using Fe3O4/polypyrrole nanocomposite. Biosens. Bioelectron. 2019, 128, 76–82. [Google Scholar] [CrossRef]
  27. Han, Q.; Wang, X.; Yang, Z.; Zhu, W.; Zhou, X.; Jiang, H. Fe3O4@rGO doped molecularly imprinted polymer membrane based on magnetic field directed self-assembly for the determination of amaranth. Talanta 2014, 123, 101–108. [Google Scholar] [CrossRef]
  28. Babamiri, B.; Hallaj, R.; Salimi, A. Ultrasensitive electrochemiluminescence immunosensor for determination of hepatitis B virus surface antigen using CdTe@CdS-PAMAM dendrimer as luminescent labels and Fe3O4 nanoparticles as magnetic beads. Sens. Actuator B Chem. 2018, 254, 551–560. [Google Scholar] [CrossRef]
  29. Rajkumar, S.; Prabaharan, M. Multi-functional core-shell Fe3O4@Au nanoparticles for cancer diagnosis and therapy. Colloids Surf. B Biointerfaces 2019, 174, 252–259. [Google Scholar]
  30. Guan, H.; Liu, B.; Gong, D.; Peng, B.; Han, B.; Zhang, N. Direct electrochemical enhanced detection of dopamine based on peroxidase-like activity of Fe3O4@Au composite nanoparticles. Microchem. J. 2021, 164, 105943. [Google Scholar] [CrossRef]
  31. Bagheri, S.; Aghaei, H.; Ghaedi, M.; Asfaram, A.; Monajjemi, M.; Bazrafshan, A.A. Synthesis of nanocomposites of iron oxide/gold (Fe3O4/Au) loaded on activated carbon and their application in water treatment by using sonochemistry: Optimization study. Ultrason. Sonochem. 2018, 41, 279–287. [Google Scholar] [CrossRef] [PubMed]
  32. Levi, N.; Khenkin, A.M.; Hailegnaw, B.; Neumann, R. Depolymerization of Cellulose in Water Catalyzed by Phenylboronic Acid Derivatives. ACS Sustain. Chem. Eng. 2016, 4, 5799–5803. [Google Scholar] [CrossRef] [Green Version]
  33. Dutta, D.; Sailapu, S.K.; Chattopadhyay, A.; Ghosh, S.S. Phenylboronic Acid Templated Gold Nanoclusters for Mucin Detection Using a Smartphone-Based Device and Targeted Cancer Cell Theranostics. ACS Appl. Mater. Interfaces 2018, 10, 3210–3218. [Google Scholar] [CrossRef]
  34. Vahlberg, C.; Linares, M.; Norman, P.; Uvdal, K. Phenylboronic Ester- and Phenylboronic Acid-Terminated Alkanethiols on Gold Surfaces. J. Phys. Chem. C 2011, 116, 796–806. [Google Scholar] [CrossRef]
  35. Wang, M.; Ye, F.; Wang, H.; Admassu, H.; Feng, Y.; Hua, X.; Yang, R. Phenylboronic Acid Functionalized Adsorbents for Selective and Reversible Adsorption of Lactulose from Syrup Mixtures. J. Agric. Food Chem. 2018, 66, 9269–9281. [Google Scholar] [CrossRef] [PubMed]
  36. Baker, G.; Desikan, R.; Thundat, T. Label-Free Sugar Detection Using Phenylboronic Acid-Functionalized Piezoresistive Microcantilevers. Anal. Chem. 2008, 80, 4860–4865. [Google Scholar] [CrossRef] [PubMed]
  37. Sankoh, S.; Thammakhet, C.; Numnuam, A.; Limbut, W.; Kanatharana, P.; Thavarungkul, P. 4-mercaptophenylboronic acid functionalized gold nanoparticles for colorimetric sialic acid detection. Biosens. Bioelectron. 2016, 85, 743–750. [Google Scholar] [CrossRef]
  38. Liu, L.; Cheng, C.; Chang, Y.; Ma, H.; Hao, Y. Two sensitive electrochemical strategies for the detection of protein kinase activity based on the 4-mercaptophenylboronic acid-induced in situ assembly of silver nanoparticles. Sens. Actuators B Chem. 2017, 248, 178–186. [Google Scholar] [CrossRef]
  39. Mo, G.; He, X.; Zhou, C.; Ya, D.; Feng, J.; Yu, C.; Deng, B. A novel ECL sensor based on a boronate affinity molecular imprinting technique and functionalized SiO2@CQDs/AuNPs/MPBA nanocomposites for sensitive determination of alpha-fetoprotein. Biosens. Bioelectron. 2019, 126, 558–564. [Google Scholar] [CrossRef] [PubMed]
  40. Chen, L.-Q.; Wang, Y.; Qu, J.-S.; Deng, J.-J.; Kang, X.-J. Selective extraction of catecholamines by packed fiber solid-phase using composite nanofibers composing of polymeric crown ether with polystyrene. Biomed. Chromatogr. 2015, 29, 103–109. [Google Scholar] [CrossRef]
  41. Özdemir, N.; Çakır, A.; Somtürk, B. Boronic acid functionalized polymeric microspheres for catecholamine isolation. Colloids Surf. A Physicochem. Eng. Asp. 2014, 445, 40–47. [Google Scholar] [CrossRef]
  42. Xie, L.; Chen, L.; Gu, P.; Wei, L.; Kang, X. A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites. J. Vis. Exp. 2018, 133, e56445. [Google Scholar] [CrossRef] [PubMed]
Separations 08 00196 g001 550
Figure 1. Molecular structures of these compounds.
Figure 1. Molecular structures of these compounds.
Separations 08 00196 g001
Separations 08 00196 g002 550
Figure 2. Schematic representation for the preparation of Fe3O4-NH2@Au-MPBA NPs and the extraction of CAs.
Figure 2. Schematic representation for the preparation of Fe3O4-NH2@Au-MPBA NPs and the extraction of CAs.
Separations 08 00196 g002
Separations 08 00196 g003 550
Figure 3. SEM (A) and the size distribution (B) of Fe3O4-NH2@Au NPs. The EDSs of Fe3O4-NH2 (C) and Fe3O4-NH2@Au NPs powder (D).
Figure 3. SEM (A) and the size distribution (B) of Fe3O4-NH2@Au NPs. The EDSs of Fe3O4-NH2 (C) and Fe3O4-NH2@Au NPs powder (D).
Separations 08 00196 g003
Separations 08 00196 g004 550
Figure 4. VSMs of Fe3O4-NH2 (a) and Fe3O4-NH2@Au NPs (b). The two bottles in the inset are both Fe3O4-NH2@Au NPs samples.
Figure 4. VSMs of Fe3O4-NH2 (a) and Fe3O4-NH2@Au NPs (b). The two bottles in the inset are both Fe3O4-NH2@Au NPs samples.
Separations 08 00196 g004
Separations 08 00196 g005 550
Figure 5. Optimizing the mass ratio of Fe3O4-NH2 and Au3+ (A), the pH value of adsorption solution (B), the reaction time of MPBA and Fe3O4-NH2@Au NPs (C), the pH value of desorption solvent (D) and elution time (E).
Figure 5. Optimizing the mass ratio of Fe3O4-NH2 and Au3+ (A), the pH value of adsorption solution (B), the reaction time of MPBA and Fe3O4-NH2@Au NPs (C), the pH value of desorption solvent (D) and elution time (E).
Separations 08 00196 g005
Separations 08 00196 g006 550
Figure 6. Liquid chromatograms of the mixed standard solution of CAs in artificial urine at 20 ng mL−1 with the extraction by magnetic NPs (A), (B) urine sample without extraction by magnetic NPs, (C) real urine sample with extraction by magnetic NPs.
Figure 6. Liquid chromatograms of the mixed standard solution of CAs in artificial urine at 20 ng mL−1 with the extraction by magnetic NPs (A), (B) urine sample without extraction by magnetic NPs, (C) real urine sample with extraction by magnetic NPs.
Separations 08 00196 g006
Table
Table 1. Parameters for methodological validation for catecholamines in artificial urine.
Table 1. Parameters for methodological validation for catecholamines in artificial urine.
CatecholaminesLinear Range
(ng mL−1)		r2Spiked Concentration
(ng mL−1)		Recovery
(%)		LOD
(ng mL−1)		LOQ
(ng mL−1)		Intraday
(RSD, %)		Interday
(RSD, %)
2.5–500.00.990710.085.40.602.08.29.3
DA50.093.27.78.8
200.095.76.17.4
2.5–500.00.991110.088.10.391.37.911.5
NE50.096.38.48.1
200.097.16.69.0
2.5–500.00.993510.089.60.270.910.78.6
EP50.098.38.37.9
200.0105.28.98.1
Table
Table 2. The concentration of CAs (NE, EP, DA) in real urine samples (M ± SD, n = 3).
Table 2. The concentration of CAs (NE, EP, DA) in real urine samples (M ± SD, n = 3).
SamplesLevel of Catecholamines (M + SD, ng/mL) (n = 3)
NEEPDA
113.2 ± 0.710.8 ± 0.381.1 ± 9.9
226.3 ± 1.125.3 ± 1.599.1 ± 10.1
365.8 ± 5.421.1 ± 1.7279.3 ± 21.6
452.6 ± 4.143.2 ± 3.5135.1 ± 14.7
565.8 ± 6.722.6 ± 1.99.0 ± 0.8
611.2 ± 0.82.7 ± 0.115.1 ± 1.3
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Han, Q.; Wu, X.; Cao, Y.; Zhang, H.; Zhao, Y.; Kang, X.; Zhu, H. Selective Separation and Analysis of Catecholamines in Urine Based on Magnetic Solid Phase Extraction by Mercaptophenylboronic Acid Functionalized Fe3O4-NH2@Au Magnetic Nanoparticles Coupled with HPLC. Separations 2021, 8, 196. https://doi.org/10.3390/separations8110196

AMA Style

Han Q, Wu X, Cao Y, Zhang H, Zhao Y, Kang X, Zhu H. Selective Separation and Analysis of Catecholamines in Urine Based on Magnetic Solid Phase Extraction by Mercaptophenylboronic Acid Functionalized Fe3O4-NH2@Au Magnetic Nanoparticles Coupled with HPLC. Separations. 2021; 8(11):196. https://doi.org/10.3390/separations8110196

Chicago/Turabian Style

Han, Qing, Xiaoxiao Wu, Yi Cao, Hua Zhang, Yuqin Zhao, Xuejun Kang, and Huaiyuan Zhu. 2021. "Selective Separation and Analysis of Catecholamines in Urine Based on Magnetic Solid Phase Extraction by Mercaptophenylboronic Acid Functionalized Fe3O4-NH2@Au Magnetic Nanoparticles Coupled with HPLC" Separations 8, no. 11: 196. https://doi.org/10.3390/separations8110196

APA Style

Han, Q., Wu, X., Cao, Y., Zhang, H., Zhao, Y., Kang, X., & Zhu, H. (2021). Selective Separation and Analysis of Catecholamines in Urine Based on Magnetic Solid Phase Extraction by Mercaptophenylboronic Acid Functionalized Fe3O4-NH2@Au Magnetic Nanoparticles Coupled with HPLC. Separations, 8(11), 196. https://doi.org/10.3390/separations8110196

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop